Stella Diagnostics (Stella Diagnostics) Investments And Advances : $0.44 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Investments And Advances?

Stella Diagnostics's Investments And Advances for the quarter that ended in Sep. 2023 was $0.44 Mil.

Stella Diagnostics's quarterly Investments And Advances stayed the same from . 20 ($0.00 Mil) to Sep. 2022 ($0.00 Mil) but then increased from Sep. 2022 ($0.00 Mil) to Sep. 2023 ($0.44 Mil).

Stella Diagnostics Investments And Advances Historical Data

The historical data trend for Stella Diagnostics's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Investments And Advances Chart

Stella Diagnostics Annual Data

Trend

Investments And Advances

Stella Diagnostics Quarterly Data
	Sep22	Sep23
Investments And Advances	-	0.44

Stella Diagnostics Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Investments And Advances

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.